Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
U.S. stocks trade mostly lower as Dow struggles to hold onto gains and China COVID-19 fears resurface
08:05pm, Monday, 21'st Nov 2022 MarketWatch
U.S. stocks are mostly lower Monday as the dollar rises on concerns about China's latest round of COVID restrictions
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
06:23pm, Monday, 21'st Nov 2022 Benzinga
HC Wainwright has initiated coverage on Denmark-based cancer firm IO Biotech Inc (NASDAQ: IOBT) with a Buy rating and a price target of $10.
The company's T-win platform works through a dual mech
Iovance (IOVA) Extends Timeline for Rolling BLA of Melanoma Drug
05:11pm, Monday, 21'st Nov 2022 Zacks Investment Research
Post FDA's feedback on lifileucel, Iovance (IOVA) extends its timeline to complete the rolling BLA submission for lifileucel in melanoma. It expects to complete the filing in the first quarter.
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
04:12pm, Monday, 21'st Nov 2022 The Motley Fool
Markets sent mixed messages to start out Thanksgiving week.
Markets will shift to a 'hope' phase next year, and investors would be wise not to miss it, says Goldman Sachs
03:06pm, Monday, 21'st Nov 2022 MarketWatch
Our call of the day from Goldman Sachs says the bear market isn't over and it will be a 'volatile' ride to the bottom. But at some point in 2023, the "hope" phase will kick in.
Is Merck & Co. (MRK) Outperforming Other Medical Stocks This Year?
02:40pm, Monday, 21'st Nov 2022 Zacks Investment Research
Here is how Merck (MRK) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Is Merck & Co. (MRK) Outperforming Other Medical Stocks This Year?
11:17am, Monday, 21'st Nov 2022
Here is how Merck (MRK) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters
10:35am, Monday, 21'st Nov 2022 Zacks Investment Research
Pfizer (PFE) and BioNTech's (BNTX) Omicron BA.4/BA.5-adapted bivalent vaccines show improved immune response against newer Omicron sublineages.
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
09:55am, Monday, 21'st Nov 2022
Biotech stock Imago BioSciences broke out and hit a record high Monday after Merck pledged to buy it for $1.35 billion. The post Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buy
Merck Making Moves, to Acquire Imago Biosciences
09:05am, Monday, 21'st Nov 2022
Merck & Co., Inc. (NYSE:MRK) is set to acquire biopharmaceutical company Imago Biosciences Inc (NASDAQ:IMGO) in a cash deal worth $1.35 billion.
Why Merck (MRK) Is Buying Imago BioSciences (IMGO) For $1.35 Billion
08:36am, Monday, 21'st Nov 2022
Merck (NYSE: MRK) announced it is buying Imago BioSciences (IMGO) for $1.35 billion. These are the details.
Imago BioSciences Stock Surges. It's Being Bought by Merck.
07:30am, Monday, 21'st Nov 2022
Merck will pay $36 in cash for each share of Imago BioSciences.
Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech
06:57am, Monday, 21'st Nov 2022
Shares of Imago BioSciences Inc. IMGO, -3.87% soared toward an eight-month high in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms
Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference
06:45am, Monday, 21'st Nov 2022
RAHWAY, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Dr. Eliav Barr, senior vice president and head of Global Clinical Developmen
2 Top Biotech Stocks to Buy Right Now
02:45pm, Saturday, 19'th Nov 2022 The Motley Fool
These two rank among the 10 largest pharmaceutical companies on the planet.
